Pharmacy Market Outlook

Plan better and budget smarter with expert insights and key analysis

Use the latest insights from our Vizient pharmacy experts to prepare your 2022 pharmacy budget. This comprehensive review includes market forecasts and drug price projections for the next 6 to 18 months, covering:

  • Acute, non-acute, specialty and pediatrics
  • Therapeutic class summaries
  • Anticipated FDA approvals
  • Market influences impacting drug spend

 3.10%
Projected drug price inflation rate
for Jan. 1, 2022-Dec. 31, 2022

Get the Pharmacy Market Outlook

Cost reduction is a top priority. Take advantage of the Pharmacy Market Outlook to guide your pharmacy team.

Syringe water drop

Top drugs by total Vizient member spend

  • Adalimumab continues to rank top of this list
  • COVID-19 treatment drug, Remdesivir, enters the chart at number 3
  • Oncology drugs continue to represent almost 25% of member spend

4.68%

Specialty pharmaceuticals
Projected drug price inflation rate*

Approval on treatments for rare diseases are at an accelerated pace.

Moving pharmacy forward

Connect with our pharmacy experts. We are here to support you.

*Based on Vizient member data April 2020-March 2021
Top categories include oncology, infectious diseases, hematological disorders and immunology.